Leiden, Netherlands

Maartje Johanna Nell

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maartje Johanna Nell: Innovator in Antimicrobial Peptides

Introduction

Maartje Johanna Nell, an accomplished inventor based in Leiden, Netherlands, has made significant contributions to the field of antimicrobial research. With a unique approach to therapy and prevention, she has developed innovative methods to combat bacterial and fungal infections.

Latest Patents

Maartje holds a patent for "Antimicrobial peptides derived from CAP18." This invention delineates methods to exert antimicrobial effects for both prophylactic and therapeutic treatments. Utilizing polypeptides that exhibit affinity to microbial and fungal toxins, her invention represents a significant advancement in the treatment of infections.

Career Highlights

Throughout her career, Maartje has been associated with prominent organizations such as Octoplus Technologies B.V. and Academisch Ziekenhuis Leiden. These affiliations highlight her expertise and commitment to advancing healthcare solutions through innovative research and development.

Collaborations

In her journey as a researcher and inventor, Maartje has collaborated with notable professionals, including Johannes Jakobus Grote and Jan Wouter Drijfhout. This teamwork has contributed to the depth and impact of her research in the fields of microbial resistance and treatment methodologies.

Conclusion

Maartje Johanna Nell stands out not only for her patent on antimicrobial peptides but also for her dedication to improving medical treatments. Her work continues to inspire innovation in the fight against infections, positioning her as a pivotal figure in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…